Supernus Pharmaceuticals, Inc.

29.08 USD
-0.02 (-0.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Supernus Pharmaceuticals, Inc. stock is up 0.73% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 58.33% of the previous 12 May’s closed higher than April. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
27 Mar 18:00 20 Sep, 2024 37.00 CALL 200 6
25 Apr 17:26 21 Jun, 2024 32.00 CALL 400 46

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the. treatment of epilepsy, as well as for the prophylaxis of migraine headache. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors.